This is a past event. Registration is closed. View other Parenteral Drug Association - Asia Pacific office events.
Ziva Abraham
CEO of MicroriteZiva Abraham is the President and Founder of Microrite, Inc., a California based consulting firm providing consulting and training services to pharmaceuticals, biotechnology, medical devices and in vitro diagnostics in the areas of quality assurance, quality control, microbiology, and validation.
She has over 35 years of academic, research, clinical and industrial experience in microbiology, and quality assurance. Ziva has received her Master’s Degree in microbiology with a focus on Mycology and has conducted research on developing microbial Insecticides using entomogenous bacteria and fungi. Her career also includes founding and managing clinical laboratories for Maccabi Medical in Israel. She has trained personnel from various industries in microbiology techniques and methods. She uses her extensive experience to teach why assessing risk of microbial contamination should be in the forefront of any company that has products for human/veterinary use. Her experience in clinical laboratories has provided her with the framework to understand the effects of microbial contamination in products from a patient safety perspective.
Duncan Barlow
Technology & Market Development Manager at Charles River Microbial SolutionsDuncan Barlow is the European Technology and Market Development Manager for Charles River Microbial Solutions division, specialising in the Accugenix microbial ID division.
He holds a BSc. from the University of Stirling and has over 20 years experience spanning testing, sales and technology adoption and implementation in the pharma, food and clinical industries.
His role with Charles River sees him supporting customers and implementation of microbial identification solutions across Europe and Asia. He has substantial experience with other QC Microbial offerings such as endotoxin testing, rapid microbiological methods and environmental monitoring
Emily Cheah (Moderator)
Managing Director of Charles River Laboratories (Singapore)A registered pharmacist, Dr. Emily Cheah is currently the Managing Director of Charles River Laboratories Singapore (Microbial Solutions). Emily oversees strategic technical operations and market development in Singapore, Malaysia, and Indonesia; and is involved in the implementation of new technology/services at the Singapore site. She also conducts numerous training for the Industry. She received her Ph.D. (Pharm. Technology) from the National University of Singapore and is currently pursuing her EMBA from INSEAD.
Emily is President-Elect of the PDA Singapore Chapter and is an active volunteer with the Chapter since its inception in 2014.
Ulrich Herber
Director of Technology and Market Development at Charles River LaboratoriesIn Ulrich's current role at Charles River, he leads a global team of Technology and Market Development Managers for the Microbial Solutions division.
Dr Herber is co-author of scientific papers on new methods applied in microbiological quality control. He has held several talks covering developments in the area of rapid microbiological methods and is an Advisory Board Member of the Pharmaceutical Microbiology Working Group at the European Compliance Academy.
Morgan Polen
Contamination Control Expert at MicroriteMorgan Polen is a subject matter expert on contamination control, airflow visualization, and particle monitoring in cleanrooms with over 35 years of industry experience.
He is a member of the ISO Technical Committee 209 (Cleanrooms and Associated Controlled Environments) and a board member of IEST and has been instrumental in drafting and editing international cleanroom standards and best practices. He has extensive experience in working on cleanroom projects in the United States, Canada, Mexico, Germany, Malaysia, Taiwan, South Korea, Singapore, Thailand, China, Philippines, India, and Turkey and is a valuable resource in addressing contamination control in critical environments for the electronics, aerospace and healthcare industries.
As a key member of Microrite’s Expert Contamination Control team, Morgan is instrumental in the development of proactive contamination control strategies through pragmatic risk assessment, troubleshooting contamination issues, and helping with FDA 483/warning letter remediation activities.